Summary
Johnson & Johnson (JNJ) filed an 8-K on April 14, 2009, to report its first-quarter financial results for the period ending March 29, 2009. The filing primarily consists of a press release detailing sales and earnings for the quarter, alongside unaudited comparative supplementary sales data and condensed consolidated statements of earnings. This report provides investors with crucial insights into the company's performance during a key period, allowing for an assessment of its operational and financial health amidst prevailing economic conditions.
Key Highlights
- 1Johnson & Johnson reported its first-quarter 2009 financial results on April 14, 2009.
- 2The 8-K filing includes a press release detailing sales and earnings for the quarter ended March 29, 2009.
- 3Unaudited comparative supplementary sales data for the first quarter is provided.
- 4Condensed consolidated statements of earnings for the first quarter are included as an exhibit.
- 5The filing serves as the official disclosure of JNJ's Q1 2009 financial performance.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally announce and provide investors with Johnson & Johnson's financial results for the first quarter ended March 29, 2009, as detailed in an accompanying press release and supplementary financial statements.
The report includes a press release announcing sales and earnings, unaudited comparative supplementary sales data, and condensed consolidated statements of earnings for the first quarter of 2009.
The specific financial figures for sales and earnings are detailed in the press release (Exhibit 99.15) and the supplementary financial statements (Exhibit 99.15) attached to this 8-K filing. Investors would need to access these exhibits for the quantitative data.